Related Experiment Video
Updated: Jul 2, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
Cardiac involvement in a female carrier of Duchenne muscular dystrophy
Insights
Female carriers of Duchenne muscular dystrophy (DMD) can experience severe cardiac issues like myocarditis and reduced left ventricular function (LVF). Early diagnosis and treatment are crucial for managing these life-threatening cardiac complications.
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- Duchenne muscular dystrophy (DMD) is a genetic disorder primarily affecting males, but female carriers can also exhibit symptoms.
- Cardiac involvement in DMD carriers is often underdiagnosed, leading to potential complications.
Observation:
- A 42-year-old female DMD carrier presented with suspected myocarditis and ventricular tachycardia.
- Cardiac imaging revealed severely reduced left ventricular function (LVF) and characteristic late gadolinium enhancement.
- Myocardial biopsy confirmed myopathic changes and abnormal dystrophin/utrophin expression, excluding viral causes.
Findings:
- Genetic analysis identified a frameshift duplication in exon 2 of the DMD gene.
- The patient's severe cardiac dysfunction was directly linked to her carrier status for DMD.
- Despite treatment, significant LVF reduction persisted at 6-month follow-up.
Implications:
- This case highlights the importance of cardiac screening in female DMD carriers.
- Early detection and management of cardiac dysfunction in DMD carriers can potentially improve outcomes.
- Understanding the genetic basis of cardiac issues in DMD carriers is vital for targeted therapies.
Abstract:
A 42 year-old female carrier of Duchenne muscular dystrophy (DMD) was referred with suspected subacute myocarditis and non-sustained ventricular tachycardia. Echochardiography and cardiac catheterization revealed severely reduced left ventricular function (LVF). Coronary artery disease was excluded. Cardiac magnetic resonance imaging showed transmural, intramural and subepicardial late gadolinium enhancement. Myocardial biopsy excluded viral infection and showed severe myopathic changes with abnormal expression of dystrophin and utrophin. Moleculargenetic analysis of the DMD gene revealed frameshift duplication of exon 2. The patient received conventional heart failure therapy, implantable cardioverter/defibrillator-implantation and prednisolone to attenuate cardiac degradation. 6 months later she had improved clinically though LVF was still severely reduced.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sex-linked Disorders
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

